Lee 2005.

Methods	Type of study: parallel RCT Type of publication: abstract Source of funding: not reported Country of origin: China Number of centres: 1 Dates of trial enrolment: not reported Length of follow‐up: 6 months Number (N) of participants randomised to each arm: 15 control and 14 BMSC Number (N) of participants analysed (primary outcome) in each arm: not reported
Participants	Population: AMI Age mean (SD) each arm: not reported Sex % male in each arm: not reported Number of diseased vessels: not reported Number of stunned hyperkinetic, etc segments: not reported Time from symptom onset to initial treatment: not reported Statistically significant baseline imbalances between the groups?: none reported
Interventions	Intervention arm: BMSC Type of stem cells: bone marrow‐derived stem cells Summary of how stem cells were isolated and type and route of delivery: not reported except the intracoronary delivery of cells Dose of stem cells: not reported Timing of stem cell procedure: 3 hours after successful PCI Comparator arm: not reported
Outcomes	Primary outcomes: changes in LV function and myocardial perfusion Secondary outcomes: not reported Outcome assessment points: 6 months Method(s):echocardiography and LV angiography
Notes	—